A randomized, open-label study of the effect of 2 different treatment schedules of Xeloda with Eloxatin and Avastin on progression-free survival in treatment-naïve patients with locally advanced or metastatic colorectal cancer

Trial Profile

A randomized, open-label study of the effect of 2 different treatment schedules of Xeloda with Eloxatin and Avastin on progression-free survival in treatment-naïve patients with locally advanced or metastatic colorectal cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 Feb 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Acronyms XELOX-A-DVS
  • Sponsors Roche
  • Most Recent Events

    • 20 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top